Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.33+0.01 (+4.05%)
Close on Nov 17, 2026Market cap $2.74MP/E –Yield –
Q/C Technologies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Q/C Technologies's enterprise value was -$8.21M on Nov 11, 2026, against $664.11K a year earlier. Over the last 5 years it ranged from -$8.40M to $5.42B, with a median of $12.90M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$8.21M | -535.6% |
| 2025 | Dec 31, 2025 | $1.88M | – |
| 2024 | Dec 31, 2024 | -$7.71M | -102.1% |
| 2023 | Dec 29, 2023 | $367.62M | -73.7% |
| 2022 | Dec 30, 2022 | $1.40B | -57.6% |
| 2021 | Dec 31, 2021 | $3.29B | +208.4% |
| 2020 | Dec 31, 2020 | $1.07B | +898.5% |
| 2019 | Dec 31, 2019 | $106.91M | -87.7% |
| 2018 | Dec 31, 2018 | $872.05M | +1024.9% |
| 2017 | Dec 29, 2017 | $77.52M | -88.6% |
| 2016 | Dec 30, 2016 | $682.12M | +68.2% |
| 2015 | Dec 31, 2015 | $405.58M | -68.7% |
| 2014 | Dec 31, 2014 | $1.29B | – |
See a number that looks wrong?